These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21220988)

  • 1. F-18 FDG PET positive hilar and mediastinal lymphadenopathy mimicking metastatic disease in a melanoma patient treated with interferon-alpha-2b.
    Kalkanis D; Kalkanis A; Gomaa O; Paes FM; Sfakianakis GN
    Clin Nucl Med; 2011 Feb; 36(2):154-5. PubMed ID: 21220988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET positive generalized lymphadenopathy and splenomegaly following interferon-alfa-2b adjuvant therapy for melanoma.
    Cone LA; Brochert A; Schulz K; Stone RA; Kazi A; Greene D
    Clin Nucl Med; 2007 Oct; 32(10):793-6. PubMed ID: 17885361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphadenopathy resulting from acute hepatitis C infection mimicking metastatic breast carcinoma on FDG PET/CT.
    Jacene HA; Stearns V; Wahl RL
    Clin Nucl Med; 2006 Jul; 31(7):379-81. PubMed ID: 16785802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive positron emission tomography scan in sarcoidosis and two challenging cases of metastatic cancer. CASE 1. Mediastinal sarcoidosis in a melanoma patient treated with interferon.
    Hendrickx BW; van Herpen CM; Bonenkamp JJ; Bulten J; Oyen WJ
    J Clin Oncol; 2005 Dec; 23(34):8906-7. PubMed ID: 16314651
    [No Abstract]   [Full Text] [Related]  

  • 5. Umbilical Plugoma Mimics Melanoma Metastasis on FDG PET/CT.
    Alabed YZ; Sakellis C
    Clin Nucl Med; 2015 Oct; 40(10):812-3. PubMed ID: 26164172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG PET/CT demonstrated rapid progression of mediastinal lymphadenopathy in sarcoidosis.
    Cheng CY; Huang WS; Shen DH; Fan YM; Hsu HH; Cherng SC; Lee SC
    Clin Nucl Med; 2007 Feb; 32(2):117-21. PubMed ID: 17242565
    [No Abstract]   [Full Text] [Related]  

  • 7. Reversible, PET-positive, generalized lymphadenopathy and splenomegaly during high-dose interferon-alpha-2b adjuvant therapy for melanoma.
    Ridolfi L; Cangini D; Galassi R; Passardi A; Marzullo A; Moretti A; Framarini M; Tauceri F; Serra L; Chiarion-Sileni V; Ridolfi R
    J Immunother; 2008 Sep; 31(7):675-8. PubMed ID: 18600177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphadenopathy resulting from acute toxoplasmosis mimicking relapse of non-Hodgkin's lymphoma on fluorodeoxyglucose positron emission tomography/computed tomography.
    Joshi P; Lele V; Mahajan P
    J Cancer Res Ther; 2012; 8(1):126-8. PubMed ID: 22531531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcoid-like reaction to malignancy on whole-body integrated (18)F-FDG PET/CT: prevalence and disease pattern.
    Chowdhury FU; Sheerin F; Bradley KM; Gleeson FV
    Clin Radiol; 2009 Jul; 64(7):675-81. PubMed ID: 19520211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solitary subcutaneous gouty nodule mimicking metastatic melanoma on FDG PET/CT.
    Edwards KW; Doss M; Huang M; Hayes SB; Walia R; Yu JQ
    Clin Nucl Med; 2015 Jun; 40(6):523-5. PubMed ID: 25608170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrarenal retroperitoneal angiomyolipoma mimicking metastatic melanoma: CT and FDG PET correlation.
    Welling RD; Lungren MP; Coleman RE
    Clin Nucl Med; 2012 Jul; 37(7):705-6. PubMed ID: 22691521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tracheal metastasis from melanoma detected with 18F-FDG PET/CT.
    Shelton T; Cambron S; Seltzer M; Siegel A
    Clin Nucl Med; 2013 Oct; 38(10):815-7. PubMed ID: 24107813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET/CT makes a significant contribution to diagnosis of malignancy in patients with cervical lymphadenopathy: a study using optimal scale regression tests.
    Ouyang L; Shi ZY; Lin ZG
    Chin Med J (Engl); 2013 Feb; 126(4):659-67. PubMed ID: 23422185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology.
    El-Bawab H; Al-Sugair AA; Rafay M; Hajjar W; Mahdy M; Al-Kattan K
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):731-6. PubMed ID: 17293120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
    Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ
    J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in the follow-up of metastatic uveal melanoma.
    Klingenstein A; Haug AR; Nentwich MM; Tiling R; Schaller UC
    Melanoma Res; 2010 Dec; 20(6):511-6. PubMed ID: 20890225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of (18)F-2-deoxy-fluoro-D-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer.
    Ozawa Y; Hara M; Sakurai K; Nakagawa M; Tamaki T; Nishio M; Shibamoto Y
    Acta Radiol; 2010 Mar; 51(2):150-5. PubMed ID: 20092375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.
    Strobel K; Dummer R; Husarik DB; Pérez Lago M; Hany TF; Steinert HC
    Radiology; 2007 Aug; 244(2):566-74. PubMed ID: 17641374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG PET for esophageal cancer complicated by sarcoidosis mimicking mediastinal and hilar lymph node metastases: two case reports.
    Takanami K; Kaneta T; Yamada T; Kinomura S; Yamada S; Fukuda H; Takahashi S
    Clin Nucl Med; 2008 Apr; 33(4):258-61. PubMed ID: 18356663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H; Henderson RW; Conti PS
    J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.